153 related articles for article (PubMed ID: 6189139)
21. Serotonin reuptake inhibition vs. norepinephrine reuptake inhibition: a double-blind differential-therapeutic study with fluvoxamine and oxaprotiline in endogenous and neurotic depressives.
Emrich HM; Berger M; Riemann D; von Zerssen D
Pharmacopsychiatry; 1987 Mar; 20(2):60-3. PubMed ID: 3108909
[TBL] [Abstract][Full Text] [Related]
22. The effect of serotonin receptor blocking agents--cyproheptadine and danitracen--on serotonin turnover in the rat brain.
Golembiowska-Nikitin K; Wiszniowska G; Marchaj J
Pol J Pharmacol Pharm; 1977; 29(5):485-95. PubMed ID: 145590
[TBL] [Abstract][Full Text] [Related]
23. Maprotiline and doxepin in the treatment of depression. A double-glind multicentre comparison.
Väisänen E; Naarala M; Kontiainen H; Meriläinen V; Heikkilä L; Malinen L
Acta Psychiatr Scand; 1978 Mar; 57(3):193-201. PubMed ID: 347885
[TBL] [Abstract][Full Text] [Related]
24. Response to maprotiline treatment in depressive patients relationship to urinary MHPG excretion and plasma drug level.
Gaertner HJ; Golfinopoulos G; Breyer-Pfaff U
Pharmacopsychiatria; 1982 Sep; 15(5):170-4. PubMed ID: 7178231
[TBL] [Abstract][Full Text] [Related]
25. Dextromethorphan inhibits 5-hydroxytryptamine uptake by human blood platelets and decreases 5-hydroxyindoleacetic acid content in rat brain.
Ahtee L
J Pharm Pharmacol; 1975 Mar; 27(3):177-80. PubMed ID: 238000
[TBL] [Abstract][Full Text] [Related]
26. Monoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients with major depression: relationship to clinical improvement.
Celada P; Pérez J; Alvarez E; Artigas F
J Clin Psychopharmacol; 1992 Oct; 12(5):309-15. PubMed ID: 1282522
[TBL] [Abstract][Full Text] [Related]
27. [Psychometric findings in treatment using the selective MAO-A inhibitors moclobemide and maprotiline].
Classen W
Psychiatr Prax; 1989 Aug; 16 Suppl 1():41-3. PubMed ID: 2587675
[TBL] [Abstract][Full Text] [Related]
28. Treatment of depression in outpatients: a controlled comparison of the onset of action of amoxapine and maprotiline.
Fabre LF
J Clin Psychiatry; 1985 Dec; 46(12):521-4. PubMed ID: 3905772
[TBL] [Abstract][Full Text] [Related]
29. Comparative cardiac effects of maprotiline and doxepin in elderly depressed patients.
Ahles S; Gwirtsman H; Halaris A; Shah P; Schwarcz G; Hill MA
J Clin Psychiatry; 1984 Nov; 45(11):460-5. PubMed ID: 6208185
[TBL] [Abstract][Full Text] [Related]
30. [Blood concentrations of maprotiline in depressive patients].
Rouillon F; Sioufi A; Serrurier D; Mizon JP; Plaquet R; Richard JB; Riche C; Bourin M; Kergueris MF; Besançon G
Encephale; 1988; 14(4):299-305. PubMed ID: 3058453
[TBL] [Abstract][Full Text] [Related]
31. Double-blind comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients. Clinical aspects.
Nyström C; Hällström T
Acta Psychiatr Scand; 1985 Jul; 72(1):6-15. PubMed ID: 2930998
[TBL] [Abstract][Full Text] [Related]
32. Trimipramine and maprotiline: antidepressant, anxiolytic, and cardiotoxic comparison.
Pecknold JC; Familamiri P; McClure DJ; Elie R; Chang H
J Clin Psychiatry; 1985 May; 46(5):166-71. PubMed ID: 2859273
[TBL] [Abstract][Full Text] [Related]
33. Relationship between blood serotonergic variables, melancholic traits, and response to antidepressant treatments.
Pérez V; Bel N; Celada P; Ortiz J; Alvarez E; Artigas F
J Clin Psychopharmacol; 1998 Jun; 18(3):222-30. PubMed ID: 9617981
[TBL] [Abstract][Full Text] [Related]
34. Differential abnormalities in plasma 5-HIAA and platelet serotonin concentrations in violent suicide attempters: relationships with impulsivity and depression.
Spreux-Varoquaux O; Alvarez JC; Berlin I; Batista G; Despierre PG; Gilton A; Cremniter D
Life Sci; 2001 Jun; 69(6):647-57. PubMed ID: 11476186
[TBL] [Abstract][Full Text] [Related]
35. Effects of zimelidine and desipramine on serotonin and noradrenaline uptake mechanisms in relation to plasma concentrations and to therapeutic effects during treatment of depression.
Aberg-Wistedt A; Jostell KG; Ross SB; Westerlund D
Psychopharmacology (Berl); 1981; 74(4):297-305. PubMed ID: 6457309
[TBL] [Abstract][Full Text] [Related]
36. [Comparison of nomifensine, maprotiline and imipramine in a double-blind study of patients with endogenous depression].
Faltus F; Filip V; Karen P; Kolomazník M; Korínková V; Libiger J; Molcan J; Zapletálek M; Zizka V
Cesk Psychiatr; 1986 Apr; 82(2):131-8. PubMed ID: 3524870
[No Abstract] [Full Text] [Related]
37. A double-blind trial comparing mianserin and maprotiline in depressed inpatients.
Palha AP; Ferreira L; Abreu-Lima C; Ramalhão C; Fernandes R
Clin Ther; 1985; 7(5):584-92. PubMed ID: 3902238
[TBL] [Abstract][Full Text] [Related]
38. Maprotiline in pain-depression.
Lindsay PG; Olsen RB
J Clin Psychiatry; 1985 Jun; 46(6):226-8. PubMed ID: 3888970
[TBL] [Abstract][Full Text] [Related]
39. Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients. Relationship to clinical improvement.
Celada P; Dolera M; Alvarez E; Artigas F
J Affect Disord; 1992 Aug; 25(4):243-9. PubMed ID: 1385505
[TBL] [Abstract][Full Text] [Related]
40. Decreased plasma serotonin in melancholic patients: a study with clomipramine.
Sarrias MJ; Artigas F; Martínez E; Gelpí E; Alvarez E; Udina C; Casas M
Biol Psychiatry; 1987 Dec; 22(12):1429-38. PubMed ID: 3676370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
